These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18609725)

  • 1. Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1464. PubMed ID: 18609725
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent tuberculosis infection amongst new recruits to the Chinese army: comparison of ELISPOT assay and tuberculin skin test.
    Wu X; Li Q; Yang Y; Zhang C; Li J; Zhang J; Liang Y; Cheng H; Zhang J; Zhu L; Zhang G; Wang L
    Clin Chim Acta; 2009 Jul; 405(1-2):110-3. PubMed ID: 19410567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients.
    Kim SH; Song KH; Choi SJ; Kim HB; Kim NJ; Oh MD; Choe KW
    Am J Med; 2009 Feb; 122(2):189-95. PubMed ID: 19185094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients.
    Hoffmann M; Reichmuth M; Fantelli K; Schoch OD; Fierz W; Furrer H; Vernazza P
    AIDS; 2007 Jan; 21(3):390-2. PubMed ID: 17255757
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers.
    Rivas I; Latorre I; Sanvisens A; Domínguez J; Tor J; Prat C; Rey-Joly C; Muga R
    Epidemiol Infect; 2009 Sep; 137(9):1342-7. PubMed ID: 19243652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM; Flogerzi B; Fallegger S; Schaffer T; Mueller S; Nicod L; Seibold F
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in the age of biologic therapy.
    Hernandez C; Cetner AS; Jordan JE; Puangsuvan SN; Robinson JK
    J Am Acad Dermatol; 2008 Sep; 59(3):363-80; quiz 382-4. PubMed ID: 18694676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embracing interferon-gamma release assays for diagnosis of latent tuberculosis infection.
    Lewinsohn DA
    Pediatr Infect Dis J; 2009 Aug; 28(8):674-5. PubMed ID: 19593251
    [No Abstract]   [Full Text] [Related]  

  • 12. [New diagnostic test for tuberculosis].
    Ravn P; Rose MV; Søborg B; Andersen AB
    Ugeskr Laeger; 2009 Sep; 171(37):2635-9. PubMed ID: 19758506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated tuberculin testing does not induce false positive ELISPOT results.
    Richeldi L; Ewer K; Losi M; Roversi P; Fabbri LM; Lalvani A
    Thorax; 2006 Feb; 61(2):180. PubMed ID: 16443712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
    Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
    Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indirect tuberculosis diagnostics. Has the Mantoux test got a successor?].
    Kronborg G; Nielsen JO
    Ugeskr Laeger; 2009 Sep; 171(37):2624. PubMed ID: 19758503
    [No Abstract]   [Full Text] [Related]  

  • 19. Latent infection and tuberculosis disease in rheumatoid arthritis patients.
    Acevedo-Vásquez E; Ponce de León D; Gamboa-Cárdenas R
    Rheum Dis Clin North Am; 2009 Feb; 35(1):163-81. PubMed ID: 19481003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostics of latent tuberculosis (TB) in adult vaccinated patients (BCG) in Croatia before introduction of tumor necrosis factor antagonist therapy].
    Popović-Grle S; Babić-Naglić D
    Reumatizam; 2008; 55(1):31-5. PubMed ID: 19024268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.